UNH stock underperforms due to rising medical costs, but has potential upside.

From MarketWatch: 2025-02-20 21:42:11

UnitedHealth Group stock has underperformed with -3% returns since the beginning of 2024, attributed to rising medical costs. Despite a 25% rise in adjusted earnings, a 22% fall in the P/E ratio has impacted stock performance. Consider the High-Quality portfolio for a smoother ride with >91% returns since inception, outperforming the S&P.

UnitedHealth’s revenue growth was driven by a 48% increase in OptumHealth’s segment. Operating margins slightly declined to 8.1% due to rising medical costs but earnings per share increased by 25%. Investor concerns over high medical costs have led to a lower P/E ratio for UNH stock, which has been volatile with inconsistent returns over the last four years.

Despite volatility, the Trefis High Quality Portfolio has outperformed the S&P 500, offering better returns with less risk. UnitedHealth Group’s valuation is estimated at $606 per share, presenting a 20% upside from the current level of $500. With room for growth, the current price dip could be an attractive entry point for long-term investors seeking growth opportunities.

Comparing returns, UNH stock has seen -3% returns since the start of 2024, while the S&P 500 is up 28%. The Trefis Reinforced Value Portfolio has achieved 21% returns since the beginning of 2024. Despite recent declines, UNH stock may have room for growth, offering a potential upside of 20% from the current price level of $500. Consider investing with Trefis Market-Beating Portfolios for optimized returns.



Read more at MarketWatch: What’s Going On With UNH Stock?